UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 188

Sortiert nach

Renal Thrombotic Microangiopathy in Concurrent COVID-19 Vaccination and Infection

Pathogens (Basel), 2021-08, Vol.10 (8), p.1045

2021

Volltextzugriff (PDF)

Longitudinal Analysis of Cardiovascular Risk Factors in Active and Sedentary Kidney Transplant Recipients

Medicina (Kaunas, Lithuania), 2020-04, Vol.56 (4), p.183

2020

Volltextzugriff (PDF)

The risks associated with percutaneous native kidney biopsies: a prospective study

Nephrology, dialysis, transplantation, 2023-02, Vol.38 (3), p.655-663

2023

Volltextzugriff (PDF)

Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient

Transplantation, 2010-03, Vol.89 (5), p.633

2010

Volltextzugriff (PDF)

Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA)

Molecular genetics and metabolism, 2008-07, Vol.94 (3), p.382-385

2008

Volltextzugriff (PDF)

Discovering uncommon nephropathies: a case of acute kidney damage from malaria

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2022-10, Vol.39 (5)

2022

Volltextzugriff (PDF)

Renal Thrombotic Microangiopathy in Concurrent COVID-19 Vaccination and Infection

Pathogens (Basel, Switzerland), 2021, Vol.10 (8)

2021

Volltextzugriff (PDF)

Dyslipidemia in Kidney transplant recipients

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2016, Vol.33 (S68)

2016

Volltextzugriff (PDF)

Metformin-associated lactic acidosis

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2015-07, Vol.32 (4)

2015

Volltextzugriff (PDF)

Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies?

Annals of hematology, 2024-05, Vol.103 (5), p.1787-1788

2024

Volltextzugriff (PDF)

A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study

Haematologica (Roma), 2016-12, Vol.101 (12), p.1544

2016

Volltextzugriff (PDF)

PB2033: ADVANCED CHRONIC MYELOMONOCYTIC LEUKEMIA IN ELDERLY AND FRAIL PATIENTS MANAGED BY AZACITIDINE IN THE FIELD OF CLINICAL PRACTICE

HemaSphere, 2023-08, Vol.7 (S3), p.e4005998-n/a

2023

Volltextzugriff (PDF)

Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms

Cancers, 2024-04, Vol.16 (8), p.1563

2024

Volltextzugriff (PDF)

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Haematologica (Roma), 2021-06, Vol.106 (6), p.1559

2021

Volltextzugriff (PDF)

Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.282-288

2015

Volltextzugriff (PDF)

Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol

Current issues in molecular biology, 2022-12, Vol.45 (1), p.164-174

2022

Volltextzugriff (PDF)

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

The lancet oncology, 2016-01, Vol.17 (1), p.27-38

2016

Volltextzugriff (PDF)

Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer

Cancers, 2022-03, Vol.14 (5), p.1357

2022

Volltextzugriff (PDF)

Quality of life considerations in myelodysplastic syndrome: not only fatigue

Expert review of hematology, 2024-08, Vol.17 (8), p.407-410

2024

Volltextzugriff (PDF)

Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?

Mediterranean journal of hematology and infectious diseases, 2024-07, Vol.16 (1), p.e2024055

Perrone, Salvatore

2024

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Renal Thrombotic Microangiopathy in Concurrent COVID-19 Vaccination and Infection

Longitudinal Analysis of Cardiovascular Risk Factors in Active and Sedentary Kidney Transplant Recipients

The risks associated with percutaneous native kidney biopsies: a prospective study

Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up

Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient

Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA)

Discovering uncommon nephropathies: a case of acute kidney damage from malaria

Renal Thrombotic Microangiopathy in Concurrent COVID-19 Vaccination and Infection

Dyslipidemia in Kidney transplant recipients

Metformin-associated lactic acidosis

Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies?

A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study

PB2033: ADVANCED CHRONIC MYELOMONOCYTIC LEUKEMIA IN ELDERLY AND FRAIL PATIENTS MANAGED BY AZACITIDINE IN THE FIELD OF CLINICAL PRACTICE

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)

Quality of life considerations in myelodysplastic syndrome: not only fatigue

High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study

Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?

Suchergebnisse filtern